| Drug Type Small molecule drug | 
| Synonyms Aspirin/hydrochlorothiazide/enalapril/atorvastatin + [1] | 
| Target | 
| Action inhibitors | 
| Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), COX inhibitors(Cyclooxygenases inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) + [1] | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date Iran (01 Feb 2018),  | 
| Regulation- | 
| Molecular FormulaC66H76CaF2N4O13 | 
| InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N | 
| CAS Registry344423-98-9 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Cardiovascular Diseases | Iran  | 01 Feb 2018 | 





